Individual immune cell and cytokine profiles determine platelet-rich plasma composition

Abstract Objective Platelet-rich plasma (PRP) therapy is increasingly popular to treat musculoskeletal diseases, including tendinopathies and osteoarthritis (OA). To date, it remains unclear to which extent PRP compositions are determined by the immune cell and cytokine profile of individuals or by...

Full description

Bibliographic Details
Main Authors: Marcel Niemann, Melanie Ort, Luis Lauterbach, Mathias Streitz, Andreas Wilhelm, Gerald Grütz, Florian N. Fleckenstein, Frank Graef, Antje Blankenstein, Simon Reinke, Ulrich Stöckle, Carsten Perka, Georg N. Duda, Sven Geißler, Tobias Winkler, Tazio Maleitzke
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-022-02969-6